Immuron Announces Positive Results of IMM-124E in Acute Colitis Research Program
News
Australia’s Immuron announced beneficial results of IMM-124E in acute models of colitis, including clinical parameters, tissue analysis, and immunological biomarkers. Colitis refers mainly to ulcerative colitis and Crohn’s disease, major categories ... Read more